Financial Forecast Revision - The company revised its 2014 net profit forecast to between 793.91 million and 882.12 million CNY, representing a decrease of 10% to 0% compared to the previous year[3] - The previous forecast estimated a net profit of 882.12 million to 1.14676 billion CNY for 2014[3] - The performance forecast revision has not been audited by registered accountants[4] Reasons for Decline - The decline in net profit is attributed to a decrease in the sales price of the company's main product, Vitamin E[5] Investor Communication - The company expressed sincere apologies for any inconvenience caused to investors due to the performance forecast revision[6]

浙江新和成股份有限公司 2014 年第三季度报告正文 证券代码：002001 证券简称：新 和 成 公告编号：2014-025 浙江新和成股份有限公司 2014 年第三季度报告正文 1 浙江新和成股份有限公司 2014 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚 假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人胡柏藩、主管会计工作负责人石观群及会计机构负责人(会计主管人员)杨徐燕声明：保证 季度报告中财务报表的真实、准确、完整。 2 浙江新和成股份有限公司 2014 年第三季度报告正文 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 8,942,780,305.71 | 8,555,874,591.90 | ...

Financial Performance - The company's operating revenue for the first half of 2014 was CNY 2,130,497,928.40, representing a 5.55% increase compared to CNY 2,018,440,079.96 in the same period last year[21]. - Net profit attributable to shareholders was CNY 548,723,718.22, a 33.46% increase from CNY 411,141,329.40 year-on-year[21]. - The net profit after deducting non-recurring gains and losses was CNY 543,999,717.00, up 29.51% from CNY 420,044,435.85 in the previous year[21]. - The net cash flow from operating activities was CNY 494,142,950.89, reflecting a 15.44% increase compared to CNY 428,666,411.07 in the same period last year[21]. - Basic earnings per share increased to CNY 0.50, a rise of 31.58% from CNY 0.38[21]. - Total assets at the end of the reporting period were CNY 8,924,304,040.75, up 4.31% from CNY 8,555,874,591.90 at the end of the previous year[21]. - Net assets attributable to shareholders increased to CNY 6,756,851,069.45, a 2.84% rise from CNY 6,570,557,702.17 at the end of the previous year[21]. - The weighted average return on equity rose to 8.16%, an increase of 1.46 percentage points compared to 6.70% in the previous year[21]. Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares for the reporting period[7]. - The company completed the registration of its increased capital stock, raising the total share capital from 725,946,000 shares to 1,088,919,000 shares[19]. - The company’s shareholder structure remains unaffected despite the increase in share capital[70]. - New Hope Holdings Group holds 56.36% of shares, totaling 613,678,257 shares, with an increase of 204,559,419 shares during the reporting period[72]. - The total number of common shareholders at the end of the reporting period is 38,288[72]. - The company did not experience any changes in its controlling shareholder or actual controller during the reporting period[74]. - The company has not reported any pledged or frozen shares among its major shareholders[72]. - The report indicates that there are no related party transactions among the top shareholders[73]. Investment and R&D - Research and development investment increased by 31.48% to 91.44 million yuan, reflecting a stronger focus on R&D[34]. - The company is actively engaged in research and development of new products, particularly in the field of food and feed additives[175]. - Future expansion plans include increasing production capacity and enhancing export services to meet growing international demand[176]. - The company is exploring new markets for its products, particularly in the Asia-Pacific region, to drive growth[176]. Financial Structure and Compliance - The governance structure of the company was improved in accordance with relevant laws and regulations, ensuring compliance and enhancing investor relations[54]. - The company adheres to the accounting standards for enterprises, ensuring compliance in its financial reporting[111]. - The financial statements are prepared based on the principle of going concern, ensuring a true and complete reflection of the company's financial status and operating results[111]. - The company has not changed its main accounting policies or estimates during the reporting period[171]. Cash Flow and Liquidity - Cash and cash equivalents at the end of the period amounted to ¥2,712,039,083.13, up from ¥2,664,710,568.85, indicating a growth of 1.8%[85]. - The company reported a net cash flow from operating activities of ¥494,142,950.89, an increase of 15.3% from ¥428,666,411.07 in the previous period[97]. - The cash flow from operating activities decreased by 11.9% from the previous period, indicating a need for strategic adjustments[98]. - The total cash and cash equivalents at the end of the period increased to ¥1,668,486,097.81, up from ¥686,724,405.65 at the end of the previous period[99]. Market Position and Competitiveness - The company’s core competitiveness remains strong, with leading market share in its main products[38]. - The company is committed to maintaining high standards in product quality and compliance with international regulations[175]. - The management provided optimistic guidance for the second half of 2014, expecting continued revenue growth and market expansion[176]. Related Party Transactions - The company engaged in significant related party transactions amounting to 5,092.47 million yuan, representing 2.51% and 1.75% of operating income from two major suppliers[62]. - The company’s related party transactions were conducted at market prices, ensuring compliance with pricing principles[62]. Asset Management - The company did not engage in any asset acquisitions or sales during the reporting period[58][59]. - The company has a total of approximately 1,590.62 million restricted shares and 1,073.0128 million unrestricted shares[109]. - The company has confirmed that impairment provisions for investments in subsidiaries, joint ventures, and associates are recognized when the carrying amount exceeds the recoverable amount[141].

Financial Performance - Operating revenue for Q1 2014 was ¥964,098,719.23, a decrease of 5.53% compared to ¥1,020,516,894.48 in the same period last year[7] - Net profit attributable to shareholders was ¥203,536,075.96, an increase of 7.34% from ¥189,617,276.49 year-on-year[7] - Basic earnings per share rose to ¥0.28, reflecting a 7.69% increase from ¥0.26 in the previous year[7] - The net profit attributable to shareholders for the first half of 2014 is expected to increase by 30% to 60%[17] - The projected net profit range for the first half of 2014 is between 534.48 million and 657.83 million yuan[17] - The net profit for the first half of 2013 was 411.14 million yuan[17] Cash Flow and Assets - Net cash flow from operating activities decreased by 24.4% to ¥242,571,640.97, down from ¥320,860,339.35 in the same period last year[7] - Total assets at the end of the reporting period were ¥8,690,024,171.22, an increase of 1.57% from ¥8,555,874,591.90 at the end of the previous year[7] - Net assets attributable to shareholders increased by 3.11% to ¥6,774,584,754.81 from ¥6,570,557,702.17 at the end of the previous year[7] Changes in Current Assets - The company reported a significant increase in other current assets by 228.68%, primarily due to the purchase of financial products during the reporting period[16] - Prepayments increased by 165.89%, mainly due to increased advance payments for housing by a subsidiary[16] Expenses and Investment - Sales expenses rose by 65.92% due to increased transportation costs associated with higher product sales volume[16] - Investment income increased by 47.7%, attributed to higher profits from associated enterprises compared to the previous year[16] Market Conditions - The increase in performance is attributed to changes in the market conditions for the company's main products, VE and VA, leading to an adjustment in their external pricing[17]

Financial Performance - The company's operating revenue for 2013 was CNY 4,237,635,148.40, representing a 16.69% increase compared to CNY 3,631,417,484.17 in 2012[24] - The net profit attributable to shareholders for 2013 was CNY 882,120,714.89, a 3.76% increase from CNY 850,172,805.14 in the previous year[24] - The total profit for 2013 was CNY 1,059.14 million, reflecting a growth of 3.92% compared to the previous year[36] - The company reported a decrease of 4.43% in net profit after deducting non-recurring gains and losses, totaling CNY 855,444,133.61 in 2013[24] - The basic earnings per share for 2013 was CNY 1.22, up 4.27% from CNY 1.17 in 2012[24] - The company reported a main business income of CNY 4,222.99 million, up 16.62% from the previous year[37] Cash Flow and Assets - The net cash flow from operating activities increased by 35.42% to CNY 1,335,018,638.43 from CNY 985,864,876.47 in 2012[24] - The company’s cash and cash equivalents increased by 166.35% to CNY 389.49 million, compared to a decrease in the previous year[50] - Total assets at the end of 2013 were CNY 8,555,874,591.90, reflecting a 9.2% increase from CNY 7,835,075,904.54 at the end of 2012[24] - Current assets rose to CNY 5,062,502,669.09, up from CNY 4,676,712,967.48, indicating an increase of about 8.2%[174] - Cash and cash equivalents increased to CNY 2,664,710,568.85 from CNY 2,368,520,031.34, a growth of approximately 12.5%[174] Investments and R&D - Research and development expenses totaled CNY 190.45 million, an increase of 18.73% compared to CNY 160.41 million in 2012[46] - The company filed 27 patent applications and received 12 patent grants during the year, indicating strong research progress[36] - The company invested a total of ¥26,626.45 million from raised funds during the reporting period, with cumulative investments reaching ¥107,822.08 million[61] Market and Competition - The company highlighted risks related to industry competition and exchange rate fluctuations, advising investors to be cautious[14] - Over 60% of the company's sales revenue comes from international markets, primarily the US and Europe, making it sensitive to exchange rate fluctuations[80] - The company faced risks related to market competition and price volatility in the vitamin market, influenced by global economic conditions[78] Shareholder and Dividend Information - The company plans to distribute a cash dividend of CNY 5.00 per 10 shares, with no bonus shares issued[6] - The company reported a cash dividend payout ratio of 100% for the current profit distribution plan, reflecting its commitment to returning value to shareholders[89] - The largest shareholder, New Hecheng Holdings Group Co., Ltd., holds 409,118,838 shares, representing 56.36% of the total shares[113] Corporate Governance and Management - The company has maintained a stable leadership structure with no changes in the board of directors or senior management during the reporting period[121] - The company has established a transparent performance evaluation and incentive mechanism linking the remuneration of directors and senior management to company performance[140] - The company has a governance structure that ensures independence from its controlling shareholder, with no interference in decision-making[139] Legal and Compliance - There were no significant litigation or arbitration matters during the reporting period, indicating a stable legal environment for the company[97] - The company maintained compliance with the Company Law and relevant regulations, ensuring no discrepancies in governance practices[142] Future Outlook - The company anticipates a recovery in market demand for vitamins and flavor products as the global economy, particularly in Europe and the US, shows signs of growth[77] - The company aims to stabilize its existing business while exploring new business opportunities and potential mergers and acquisitions to accelerate growth[77]